A phase I study of cisplatin, methotrexate, levofolinic acid and 5- fluorouracil in advanced squamous cell carcinoma of the head and neck

Oncology Reports

Volumn 4, Issue 6, 1997, Pages 1207-1211

  Caponigro, Francesco ^a   Comella, Pasquale ^a   Daponte, Antonio ^a   Gravina, Adriano ^a   Carteni, Giacomo ^b   Biglietto, Maria ^b   Casaretti, Rossana ^a   Frasci, Giuseppe ^a   Ionna, Franco ^a   Mozzillo, Nicola ^a   Comella, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

5 fluorouracil; Cisplatin; Folinic acid; Head and neck cancer; Methotrexate

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; GASTROINTESTINAL TOXICITY; HEAD AND NECK CARCINOMA; HUMAN; MALE; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEUROTOXICITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0030952567     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.6.1207     Document Type: Article

References (37)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54: 594-606, 1993.
2. Wynder EL, Bross IJ and Feldman RM: A study of the etiological factors in cancer of the mouth. Cancer 19: 1300-1323, 1957.
3. Vokes EE, Weichselbaum RR, Lippman SM and Hong WK: Head and neck cancer. N Engl J Med 328: 184-194, 1993.
4. Dimery IW and Hong WK: Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85: 95-111, 1993.
5. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324: 1685-1690, 1991.
6. Demard F, Chauvel P, Santini J, et al: Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas. Head Neck 12: 225-231, 1990.
7. Jaulery C, Rodriguez J, Brunin F, et al: Induction chemotherapy in advanced head and neck tumors: results of two randomized trials. Int J Radiat Oncol Biol Phys 23: 483-489, 1992.
8. Head and Neck Contracts Program: Adjuvant chemotherapy for advanced head and neck squamous carcinoma: final report. Cancer 60: 301-311, 1987.
9. Merlano M, Benasso M, Corvo R, et al: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88: 583-589, 1996.
10. Thyss A, Schneider M, Santini J, et al: Induction chemotherapy with cisplatinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. Br J Cancer 54: 755-760, 1986.
11. Jacobs C, Lyman G, Velez-Garcia E, Sridhar KS, Knight W, Hochster H, Goodnough LT, Mortimer JE, Einhorn LH, Schacter L, Cherug N, Dalton T, Burroughs J and Rozencweig M: A phase III randomized study comparing cisplatin and 5-fluorouracil as single agent and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10: 257-263, 1992.
12. Schneider M, Etienne MC, Milano G, Thyss A, Otto J, Dassonville O, Mobayen H, Saudes L, Guillot T and Demand F: Phase II trial of cisplatin, fluorouracil and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey. J Clin Oncol 13: 1656-1662, 1995.
13. Gebbia V, Testa A, Valenza R, Zerillo G, Restivo S, Cupido G, Ingria F, Barbaccia C, Spadafora G, Cannata G and Gebbia N: A phase II study of levofolin acid and fluorouracil plus cisplatin in patients with advanced head and neck carcinoma. Oncology 50: 490-494, 1993.
14. Vokes EE, Moran WJ, Mick R, et al: Neoadjuvant and adjuvant methotrexate, cisplatin and fluorouracil in multimodal therapy of head and neck cancer. J Clin Oncol 7: 838-845, 1989.
15. Vokes EE, Choi KE, Schilsky RL, et al: Cisplatin, fluorouracil and high-dose leucovorin for recurrent or metastatic head and neck cancer. J Clin Oncol 6: 618-626, 1988.
16. Schneider M, Demard F, Chauvel P, et al: Induction chemotherapy with cisplatinum and continuous infusion 5-FU for the treatment of head and neck cancer. Six year experience at the Nice Cancer Center. In: Neoadjuvant Chemotherapy, Third International Congress. Banzet P, Holland JF, Khayat D, (eds). Springer-Verlag, Paris, pp18-23, 1991.
17. Arbuck SG: Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer 63: 1036-1039, 1989.
18. Dreyfuss AI, Clark JR, Wright JE, et al: Continuous infusion of high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med 112: 167-172, 1990.
19. Vokes EE, Schilsky RL, Weichselbaum RR, et al: Induction chemotherapy with cisplatin, fluorouracil and high-dose leucovorin for locally advanced head and neck cancer. J Clin Oncol 8: 241-247, 1990.
20. Houghton JA, Schmidt C and Houghton PJ: The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthase covalent complex in human colon xenografts. Eur J Cancer Clin Oncol 18: 347-350, 1982.
21. Bertino JR, Mosher MB and de Conti RC: Chemotherapy of cancer of the head and neck. Cancer 31: 1141-1149, 1973.
22. Bertino JR, Sawicki WL, Linquist CA, et al: Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil. Cancer Res 37: 327-328, 1977.
23. Allegra CJ: Methotrexate and fluorouracil following tamoxifen and premarin in advanced breast cancer. Semin Oncol 10 (Suppl 2): 23-28, 1983.
24. The Advanced Colorectal Cancer Meta-Analysis Project: Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 12: 960-969, 1994.
25. Athanasiadis I and Vokes EE: Expanding role of chemotherapy for head and neck squamous cell carcinoma. Adv Oncol 11: 22-30, 1995.
26. Scanlon KJ, Newman EM, Lu Y, et al: Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 83: 8923-8926, 1986.
27. Stupp R, Weichselbaum RR and Vokes EE: Combined modality therapy of head and neck cancer. Semin Oncol 21: 349-358, 1994.
28. Ensley J, Kish J, Tapazoglou E, et al: An intensive five course alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer. J Clin Oncol 6: 1147-1153, 1988.
29. Kish JA, Ensley JF, Jacobs JR, et al: Evaluation of high dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancer. Am J Clin Oncol 11: 553-557, 1988.
30. Haines I, Bosi G, Pfister D, Spiro R, Gerald F, Sessious R, Shah J, Strong E, Vikram B and Harrison L: Very high dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer. J Clin Oncol 5: 1594-1600, 1987.
31. Vokes EE, Kies M, Haraf DJ, Mick R, Moran WJ, Korloff H, Mittal B, Pelzen H, Wenig B, Panje W and Weichselbaum RR: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol 13: 876-883, 1995.
32. Vokes EE, Ratain MJ, Mick R, McEvilly JM, Haraf D, Korloff M, Hamasaki V, Weichselbaum RR, Parjie WR, Wenig B and Berezin F: Cisplatin, fluorouracil and leucovorin augmented by interferon alpha-2b in head and neck cancer: a clinical and pharmacologic analysis. J Clin Oncol 11: 360-368, 1993.
33. Vokes EE, Mick R, Kies MS, et al: Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer. J Clin Oncol 14: 1663-1671, 1996.
34. Comella P, Palmieri G, Beneduce G, Casaretti R, Daponte A, Gravina A, Frasci G, Biondi E and Comella P: Significance of methotrexate serum level achieved in patients with gastrointestinal malignancies treated with sequential methotrexate, 1-folinic acid and 5-fluorouracil. Oncology 53: 198-203, 1996.
35. Comella P, Palmieri G, Lorusso V, Catalano G, Nicolella D, Ianniello GP, Casaretti R, Montella M, Frasci G, Perna M and Comella G: Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies. Eur J Cancer 32: 1719-1726, 1996.
36. Marsh JC, Bertino JR, Katz KH, Davis CA, Durivage HJ, Rone LS, Richards F, Capizzi RL, Farbar LL, Stuart R, Koletsky AJ, Makuch R and O'Hollaren K: The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer. J Clin Oncol 9: 371-380, 1991.
37. Rustum JM: Rationale for the combination of 5-fluorouracil/ leucovorin: role of dose, schedule and route of administration. In: Leucovorin Modulation of Fluoropyrimidines: A New Frontier in Cancer Chemotherapy. Pinedo HM and Rustum JM (eds). Royal Society of Medicine Services, London, pp11-19, 1989.